Xenon Pharmaceuticals Inc. Recorded Big Gain
Wed, Oct 06, 2021 at 05:32 PM
Xenon Pharmaceuticals Inc. (XENE:NASDAQ) rocketted at $32.03, representing a gain of 105.3%. On Tue, Oct 05, 2021, XENE:NASDAQ hit a New 2-Week Intraday High of $33.7. The stock appeared on our News Catalysts scanner on Wed, Oct 06, 2021 at 03:14 AM in the 'PUBLIC OFFERING' category. From Tue, Sep 21, 2021, the stock recorded 50.00% Up Days and 36.36% Green Days
About Xenon Pharmaceuticals Inc. (XENE:NASDAQ)
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing a pipeline of differentiated therapeutics for orphan indications. Its products portfolio includes Glybera, TV-45070.
Top 10 Gainers:
- Xenon Pharmaceuticals Inc. (XENE:NASDAQ), 105.32%
- PPHP (PPHP:NASDAQ), 100%
- WINV (WINV:NASDAQ), 100%
- APMI (APMI:NASDAQ), 100%
- Elmira Savings Bank (ESBK:NASDAQ), 67.78%
- GROM (GROM:NASDAQ), 52.29%
- Voyager Therapeutics, Inc. (VYGR:NASDAQ), 48.28%
- LGHL (LGHL:NASDAQ), 46%
- BTBT (BTBT:NASDAQ), 39.03%
- ZETA (ZETA:NYSE), 29.82%